These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 9143294)
1. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294 [TBL] [Abstract][Full Text] [Related]
2. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778 [TBL] [Abstract][Full Text] [Related]
3. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116 [TBL] [Abstract][Full Text] [Related]
4. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus. Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387 [TBL] [Abstract][Full Text] [Related]
5. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein. Bonaldo MC; Garratt RC; Freire MS; Galler R Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518 [TBL] [Abstract][Full Text] [Related]
6. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547 [TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Jennings AD; Whitby JE; Minor PD; Barrett AD Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Engel AR; Vasconcelos PF; McArthur MA; Barrett AD Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518 [TBL] [Abstract][Full Text] [Related]
12. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools. Gould EA; Buckley A; Cane PA; Higgs S; Cammack N J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467 [TBL] [Abstract][Full Text] [Related]
13. Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice. Miller BR; Adkins D Acta Virol; 1988 May; 32(3):227-34. PubMed ID: 2902770 [TBL] [Abstract][Full Text] [Related]
14. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. Schlesinger JJ; Brandriss MW; Walsh EE J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501 [TBL] [Abstract][Full Text] [Related]
15. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex. Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT mBio; 2019 Oct; 10(5):. PubMed ID: 31641088 [TBL] [Abstract][Full Text] [Related]
17. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus. Xie H; Ryman KD; Campbell GA; Barrett AD J Gen Virol; 1998 Aug; 79 ( Pt 8)():1895-9. PubMed ID: 9714237 [TBL] [Abstract][Full Text] [Related]
18. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants. Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103 [TBL] [Abstract][Full Text] [Related]
19. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837 [TBL] [Abstract][Full Text] [Related]
20. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]